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Different methods and data sources have been utilized to determine the relationship between malaria 
and mortality in endemic countries. Most of these efforts have focused on deaths directly attributed 
to malaria, while they overlooked causes of mortality that might be indirectly related to the disease, 
for instance anemia. We estimated the association of malaria parasitaemia, anemia, and malaria-
anemia comorbidity with all-cause under-five mortality and evaluated the potential of malaria-anemia 
comorbidity prevalence to quantify malaria-related deaths in sub-Saharan Africa. We analysed data 
from Demographic and Health Surveys (DHS) and employed Bayesian geostatistical models. Mortality 
hazard obtained from malaria-anemia comorbidity prevalence was up to 3·5 times higher compared 
to the hazard related to Plasmodium parasitaemia only. Malaria parasite prevalence alone could not 
always capture a statistically important association with under-five mortality. Geographical variation of 
the malaria-anemia comorbidity effect was observed in most, but not all, countries. We concluded that 
the malaria burden in sub-Saharan Africa is considerably underestimated when anemia in not taken into 
account and that the malaria-anemia comorbidity prevalence provides a useful measure of the malaria-
related deaths.
In 2016, malaria caused an estimated 216 million clinical episodes and 445,000 deaths1. Sub-Saharan Africa is 
the most afflicted region globally; indeed, 91% of all malaria deaths are concentrated in this part of the world. 
Children under the age of 5 years are at highest risk and might contribute up to 70% of all malaria-related deaths. 
Large-scale control efforts led to an 18% reduction in the incidence rate of malaria between 2000 and 2016 and 
six countries were certified by the World Health Organization (WHO) as malaria-free1. In 2016, the financial 
investment in malaria control and elimination was estimated at US$ 2·7 billion. Eliminating malaria by 2030 is 
part of the aspirations of the Sustainable Development Goals (SDGs)2. The 10 sub-Saharan African countries with 
the highest malaria burden experienced an increase in malaria incidence from 2015 to 2016, therefore the WHO 
recently launched the 10 + 1 initiative3 which aims to renew the focus on achieving the objectives set up by the 
Global Technical Strategy and Sustainable Development Goals.
Understanding the relation between malaria transmission and malaria-related mortality provides a useful 
insight in monitoring and evaluation of malaria control and elimination efforts. Furthermore, it helps in the 
planning of interventions since regions that are expected to have high malaria deaths could have interventions in 
place, such as availability of rapid diagnostic tests (RDTs) and Artemisinin-based combination therapy (ACT) in 
health facilities and information campaigns to prevent progression to severe malaria and therefore death. Several 
approaches and different data sources have been utilized to quantify malaria-related deaths. For example, the 
‘Malaria Transmission Intensity and Mortality Burden across Africa’ (MTIMBA) project collected geo-referenced 
entomological data, which were linked with all-cause and malaria-specific mortality data derived from health and 
demographic surveillance systems (HDSS). A geostatistical analysis4 of the MTIMBA data from the Rufiji HDSS 
in Tanzania found no significant relation between neonate, infant, and 1- to 4-year-old child survival with malaria 
transmission, the latter measured by the entomological inoculation rate (EIR). In contrast, a 5-year collection 
of monthly data from the Kisumu HDSS in Kenya revealed a strong association between malaria-mortality and 
malaria transmission, the latter determined by the slide positivity rate (SPR)5. Malaria survey and mortality data 
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from the Demographic and Health Surveys (DHS) linked to malaria incidence from the Malaria Atlas Project 
(MAP) suggested a 57% decrease of malaria-related mortality during 1990–20156. However, analyses of DHS 
mortality data from Mali and Malawi with historical malaria survey data were not able to capture a statistically 
significant malaria-mortality relation7,8. A systematic analysis9 of malaria mortality data between 1980 and 2010 
estimated 1·238 million malaria deaths globally in 2010.
Most of the studies estimating malaria-related deaths overlooked indirect causes of malaria mortality10. 
Indeed, one of the main outcomes of Plasmodium infection is anemia caused by the rupture of red blood cells 
as part of the complex life cycle11. P. falciparum leads to severe malarial anemia, which might be responsible 
for around one third of malaria deaths12. Righetti and colleagues13 reported a significant negative association 
between Plasmodium infections and haemoglobin concentrations. Another study reported stronger associations 
of anemia with malaria than iron deficiency or other nutritional, infectious, and genetic contributors14. Despite 
the proven association between anemia, malaria, and mortality, modelling studies quantifying the association 
between malaria-anemia comorbidity and under-five mortality are rather few.
We estimated the association of malaria parasitaemia, anemia, and malaria-anemia comorbidity with 
all-cause under-five mortality and evaluated the potential of malaria-anemia comorbidity prevalence to quantify 
malaria-related deaths in sub-Saharan Africa. We compiled available household-based data collected from DHS 
and Malaria Indicator Surveys (MIS) and employed a rigorous Bayesian geostatistical modeling framework. We 
estimated within-country variation of the association between comorbidity and under-5 mortality, using spatially 
varying coefficient models. Our results are presented at high spatial resolution, including model-based risk maps 
of malaria, anemia, and malaria-anemia comorbidity.
Results
A total of 8,116 unique locations from 16 sub-Saharan Africa countries were included in this study. Of these, 
Angola, Benin, and Uganda have the highest number of locations. The earliest survey from which we extracted 
data is from Burkina Faso, conducted in 2010, while the latest is from Burundi, conducted in 2016–2017. Malaria 
prevalence among children under 5 years ranged from 2.2% in Rwanda to 76.1% in Burkina Faso. All countries 
of West Africa, except Senegal, had higher malaria prevalence compared to East African countries. The highest 
moderate/severe anemia prevalence was found in Burkina Faso (69.6%). Burkina Faso, Guinea, and Cameroon 
showed, in descending order, the highest under-five mortality rate. Despite relatively high malaria parasitaemia 
and anemia levels, Ghana revealed the second lowest under-five mortality rate among the 16 countries examined. 
Burkina Faso, Burundi, Mozambique, and Uganda were the four countries characterized by a higher malaria bur-
den compared to the anemia burden. All countries except Burkina Faso (11.1%) had severe anemia levels below 
10% with the lowest rate observed in Rwanda (0.7%). Overall, the mean malaria prevalence was 31.1%, mean 
moderate/severe anemia was 39.7%, and mean severe anemia was 3.7%.
Our estimates (Fig. 1) highlight a statistically important effect of comorbidity on under-five mortality across 
all countries, except Rwanda and Tanzania. We identified a statistically important effect of malaria-anemia 
Figure 1. Bayesian estimates (posterior median, 95% BCI) of malaria parasitaemia, moderate/severe anemia 
(<100 g/l), severe anemia (<70 g/l), comorbidity, and severe comorbidity prevalence on under-five mortality 
in 16 sub-Sahara African countries. Models were adjusted for climate, maternal and household characteristics, 
malaria- anemia interventions, and individual child covariates. ANG, Angola; BEN, Benin; BFA, Burkina Faso; 
BUR, Burundi; CAM, Cameroon; CIV, Côte d’Ivoire; DRC, Democratic Republic of the Congo; GHA, Ghana; 
GUI, Guinea; MAL, Mali; MOZ, Mozambique; RWA, Rwanda; SEN, Senegal; TAZ, Tanzania; TOG, Togo; UGA, 
Uganda.
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comorbidity on under-five mortality in 14 out of 16 countries (except Rwanda and Tanzania), while malaria 
prevalence alone was statistically important in half of the countries. In Benin, the hazard ratio (HR) of comorbid-
ity was 3·5 times the hazard ratio of parasitaemia alone. The HR of comorbidity was approximately 50% higher 
in Cameroon, Mozambique, and Togo and approximately 30% higher in Uganda and the Democratic Republic 
of the Congo compared to the HR of parasitaemia alone. We observed the lowest difference in hazard ratios in 
Angola and Mali, with 7% and 3% higher malaria-anemia comorbidity hazard, respectively. Burkina Faso was the 
only country with an important comorbidity effect and no statistically important difference in the hazard ratios 
of comorbidity and parasitaemia.
Using the same set of confounders across all countries, we found a statistically important associa-
tion of malaria-anemia comorbidity prevalence with under-five mortality in 9 out of 16 countries examined 
(Supplementary Appendix, Table 1.3). Similarly to the results above, the comorbidity prevalence was associated 
with mortality in countries which did not have an important parasitaemia-mortality relation. In countries with a 
significant parasitaemia-mortality association, the coefficient of the comorbidity was greater than that of parasi-
taemia (except Burkina Faso, as observed with country-specific covariates). Estimates for the comorbidity preva-
lence, adjusted for parasitaemia only prevalence, anemia only prevalence and country-specific confounders, were 
higher in 7 out of 11 countries compared to unadjusted models for parasitaemia and anemia only prevalences 
(Supplementary Appendix, Table 1.4). However, in the adjusted analyses the comorbidity was not statistically 
important in Angola, Guinea and Mali.
Severe disease expressed either as severe anemia or severe comorbidity has the highest burden on under-five 
mortality. As all countries have relatively low severe anemia prevalence, there is high uncertainty in our esti-
mates, contributing to important associations only in 4 out of the 16 countries investigated (Fig. 1). However, 
when the severe comorbidity-mortality relation is captured, the HR can be more than five times higher to that 
of comorbidity, as observed in Cameroon and Côte d’Ivoire. Similarly, when we identify an important severe 
anemia-mortality association, the HR estimates of severe anemia are greater than the ones of comorbidity, albeit 
lower than that of severe comorbidity. Hence it can be inferred that severe disease has the greatest impact on 
under-five survival.
Figure 2 demonstrates the geographical distribution of the comorbidity association with all-cause under-five 
mortality. All countries with a statistically important comorbidity effect at national level demonstrate subna-
tional geographical variations. In some countries (i.e. Benin, Côte d’Ivoire, Democratic Republic of the Congo 
and Mozambique) there are large areas with a statistically important comorbidity effect. In others, (i.e. Angola, 
Burkina Faso, Burundi, Cameroon and Ghana) the effect is rather focal.
Model-based risk surfaces of the comorbidity effect on under-five mortality are presented in Fig. 3 and of 
malaria parasitaemia and anemia in the Supplementary Appendix. In some countries, we observed strong spa-
tial patterns of moderate-to-severe anemia risk surfaces while in others there are only a few high risk hotspots. 
Noteworthy are areas in which high malaria parasitaemia risk coincides with densely populated surfaces, for 
example in northern Burundi, central-south Cameroon, central Guinea, and north-east Mozambique. Severe 
anemia-malaria maps refine all areas of high risk within a country and demonstrate regions of severe disease, i.e. 
areas between Lunda Sul and the Moxico border in Angola, Ngozi province in Burundi, Mopti province in Mali, 
the south-eastern part of Senegal, North Tanzania, and the south-western part of Côte d’Ivoire.
Discussion
This is the first study assessing the association of malaria-anemia comorbidity with child mortality using rou-
tinely collected household survey data from DHS and MIS. We employed Bayesian geostatistical modeling and 
rigorous variable selection procedures to assess the geographical variation of the comorbidity effect on under-five 
mortality. We included in the analysis survey data with information on mortality, anemia and malaria at the same 
location to avoid potential bias from surveys misaligned in space and time.
Our findings demonstrate a strong association between under-five mortality and comorbidity burden, sug-
gesting that higher prevalence of the comorbidity are related to higher mortality rates. Low malaria parasite prev-
alence, low under-five mortality, and moderate-to-high malaria intervention coverage were observed in countries 
with no statistically important comorbidity effects (i.e. Rwanda and Tanzania). In countries with a statistically 
important malaria-mortality relation, with the exception of Burkina Faso, the mortality hazard of comorbidity 
was higher than the mortality hazard of parasitaemia. A cross-sectional study in Rwanda found that children with 
moderate/severe anemia had a four times higher risk of malaria infection15. A prospective observational study 
in Gabon16 showed that moderate/severe malarial anemia was strongly associated with parasitaemia in children 
aged below four years. Other studies17–21 also suggested a strong relationship between malaria and anemia, irre-
spective of the malaria prevalence levels22. Our work demonstrates that moderate anemic children with malaria 
parasites have higher mortality hazards compared to those children with only parasitaemia.
When a common set of confounders was used across all models, we observed an important 
comorbidity-mortality association in fewer countries, albeit these countries did not have an impor-
tant parasitaemia-mortality association. This modelling approach incorporates, in each model, unneces-
sary covariates and it does not take into account multicollinearity which can bias parameter estimation. The 
mortality-comorbidity association was not statistically important in Angola, Guinea and Mali when the model 
was adjusted for parasitaemia only and anemia only prevalences. In fact these countries have the highest anemia 
only prevalence (together with Senegal and Tanzania) which may explain the variation in mortality. We have 
adjusted for the malaria/anemia only to avoid high correlation with the comorbidity prevalence.
Among the factors investigated in our study, severe comorbidity has the highest impact on all-cause under-five 
mortality. Due to the low severe comorbidity prevalence, we obtained higher uncertainty in our estimates and 
thus we were only able to find an important association with under-five mortality in Cameroon, Côte d’Ivo-
ire, Democratic Republic of the Congo, and Uganda. In these countries, the magnitude of association of severe 
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comorbidity is far greater compared to that of other conditions and types of diseases examined. A study from the 
University Teaching Hospital in Ebonyi state in Nigeria showed that malaria accounted for approximately 77% 
of all children with severe anemia admission in the hospital23 and associated severe anemia with high under-five 
mortality rates. In western Kenya, an association of 85% between parasitaemia and severe anemia in hospital 
admissions is reported24, with severe anemia contributing to approximately half of malaria-related deaths. Severe 
comorbidity accounts for more than 30% in paediatric mortality25. Apart from profound results on children sur-
vival, severe malarial anemia could also be associated with long-term impairment in cognitive ability26.
Figure 2. Posterior median of the malaria-anemia comorbidity effect on all-cause under-five mortality. Effects 
which are not statistically important (pixel-level posterior distribution includes zero) are indicated in grey 
colour.
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Our findings revealed considerable geographical variation of the malaria-anemia comorbidity effect on 
all-cause under-five mortality in most countries. Several geographical areas with important comorbidity associa-
tion coincide with known areas in which high mortality and low antimalarial treatment or ITN coverage exists6, 
for instance areas in Lunda Norte, Huila and Malanje provinces in Angola, Orientale, Katanga and Kivu provinces 
in Democratic Republic of the Congo, parts in north Cameroon and central Côte d’Ivoire, Faranan and Kankan 
provinces in Guinea and most of the areas shown in Mali. Additionally, some of the areas reside in provinces 
that experienced severe malaria burden at the year that the DHS-MIS was conducted, for instance the Orientale 
province in Democratic Republic of the Congo27.
Figure 3. Posterior median of malaria parasitaemia and moderate or severe anemia comorbidity risk estimates 
at 2 × 2 km2 from Bayesian geostatistical models for 16 sub-Sahara African countries.
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In countries lacking a clear malaria-mortality relation, we found an important anemia-mortality association. 
Democratic Republic of the Congo, Mozambique, and Uganda are the only countries in this study showing that 
both malaria parasite and anemia prevalence are related to mortality. Greenwell and Neuman28 supported that 
anemia is an important indicator for monitoring malaria burden. Based on our findings, the malaria-anemia 
comorbidity indicator could be used to monitor severe disease.
Our work assessed the potential of anemia and malaria parasitaemia comorbidity prevalence to estimate 
malaria-related under-five mortality. Our findings confirm earlier results showing that malaria parasite prev-
alence alone fails to fully capture a statistically important association with mortality. Presence of malaria par-
asites is not directly linked to severe malaria that leads to death and thus statistical models may fail to capture 
the known association between malaria and mortality. In contrast, the comorbidity indicator can identify cases 
that experience severe disease, and hence, it is better related to mortality. It follows that the effect of comorbidity 
prevalence on all-cause under-five mortality can be a better indicator of malaria-related deaths than malaria 
prevalence alone, in survey data. Studies should further evaluate the use of comorbidity indicator in estimating 
malaria deaths for under-five children using malaria-specific mortality data.
Our work does not take into account changes in prevalence that might have been occurred over the last 
five years that mortality has been studied. This assumption may influence data stemming from the most recent 
surveys, when the scaling up of malaria interventions had already taken place. Yet, our analysis includes mostly 
surveys conducted before 2013, thus before the further scaling up of interventions. In our study the estimated 
effects are quantifying associations and by no means imply causal relations. Children with severe malaria anemia 
are less likely to participate in DHS or MIS, leading to underestimation of this effect.
Methods
Data sources. We analysed household representative survey data from 16 sub-Saharan African countries that 
had available malaria, anemia, and mortality data at survey locations. The surveys were conducted between 2010 
and 2017. A summary of the data extracted from the DHS is provided in Table 1.
For each child, the mortality-related data consisted of the age and vital status (i.e. alive or dead) of the child. 
Furthermore, we considered in the analysis information on maternal, household and individual child character-
istics. Maternal data included the educational attainment and literacy of the mother, age at pregnancy, delivery 
methods, other pregnancy terminations, and time intervals succeeding or preceding birth. Each child was classi-
fied into a socioeconomic category, using a household-based asset index which was already available in the data29. 
We also obtained information on the living standards of each child (e. g. improved sanitation facilities, improved 
drinking water sources, and open defecation practises). Individual child covariates included the sex of a child, 
birth order, breastfeeding practises of the mothers, and vaccination status.
Malaria and anemia data were extracted from readily available MIS. Some of the surveys used a combination 
of malaria microscopy and rapid diagnostic tests (RDTs) to diagnose malaria, while others used RDTs only. We 
classified the anemia level of a child based on guidelines put forward by the World Health Organization (WHO), 
as follows: (i) moderate or severe anemic if haemoglobin (Hb) levels were below 100 g/l and (ii) severe anemic if 
Hb levels were below 70 g/l. We also considered indicators of malaria intervention coverage at cluster level such as 
the proportion of households reporting indoor residual spraying (IRS), Artemisinin-based combination therapy 
coverage, the proportion of use or ownership of insecticide-treated nets (ITN), and the prevalence of iron supple-
mentation in order to adjust for interventions. We defined comorbidity as malaria parasitaemia with moderate 
Country Survey period
Number of 
locations
Malaria 
parasitaemia* (%)
Moderate/
severe anemia* 
(<100 g/l)
Severe 
Anemia* 
(<70 g/l)
Moderate 
comorbidity*
Severe 
comorbidity* ITN** U5M***
Angola 10/2015–3/2016 625 13.1% (R) 34·0 2·2 10·1 1·5 31·0 68
Benin 12/2011–4/2012 747 28.4% (M) 32·1 3·0 10·9 1·0 79·8 70
Burkina Faso 1/2010–12/2010 542 76.1% (R) 69·6 11·1 53·2 8·5 56·9 129
Burundi 10/2016–3/2017 552 37.9% (R) 36·3 3·6 21·0 2·9 46·1 78
Cameroon 1/2011–8/2011 577 30.0% (R) 32·8 1·7 16·8 1·4 36·4 122
Côte d’Ivoire 12/2011–5/2012 341 41.5% (R) 49·7 3·3 27·7 2·4 67·3 108
DRC 8/2013–2/2014 492 22.6% (M) 27·1 2·3 11·9 1·4 70·0 104
Ghana 9/2014–12/2014 423 36.4% (R) 39·1 2·2 25·0 2·1 68·3 60
Guinea 6/2012–10/2012 300 43.9% (M) 52·4 7·6 27·0 4·9 47·0 123
Mali 11/2012–2/2013 413 51.6% (R) 60·8 9·3 33·4 6·7 84·4 95
Mozambique 5/2011–12/2011 610 38.3% (R) 26·6 1·4 21·7 2·7 51·4 97
Rwanda 11/2014–4/2015 492 2.2% (M) 15·7 0·7 1·5 0·2 80·6 50
Senegal 10/2010–4/2011 385 2.9% (M) 53·2 4·9 2·5 0·6 62·9 72
Tanzania 8/2015–2/2016 608 5.6% (M) 31·2 1·6 2·4 0·2 65·6 67
Togo 10/2013–4/2014 330 36.4% (M) 44·8 2·4 22·5 1·8 65·4 88
Uganda 6/2016–12/2016 679 30.3% (R) 29·2 2·3 17·1 1·8 78·4 64
Table 1. Descriptive analysis of malaria survey data in 16 sub-Sahara African countries, collected from the 
DHS programme. *Representing prevalence; **Insecticide-treated net ownership; ***Under-five mortality (per 
1,000); ****M for microscopy rest; R for RDT.
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or severe anemia and severe comorbidity as parasitaemia with severe anemia. The DHS Program maintains strict 
standards for protecting the privacy of respondents and household members in all DHS surveys. Before each 
interview or biomarker test is conducted, an informed consent statement is read to the respondent, who may 
accept or decline to participate. Also, verbal informed consent for each parasitaemia test is provided by the child’s 
parent/guardian/caregiver on behalf of children less than 5 years before the test is conducted. Verbal consent is 
conducted by the interviewer reading a prescribed statement to the respondent and recording in the question-
naire whether or not the respondent consented or assent is provided. The interviewer signs his or her name attest-
ing to the fact that he/she read the consent statement to the respondent. Written consent is not included (https://
dhsprogram.com/publications/publication-dhsm7-dhs-questionnaires-and-manuals.cfm).
We extracted environmental and climatic data from remote sensing and other open access data sources. We 
downloaded from Moderate Resolution Imaging Spectroradiometer (MODIS) the normalized difference vegeta-
tion index (NDVI) and the land surface temperature (LST) at 1 × 1 km2 spatial resolution. We also obtained from 
MODIS the land cover type (LC) and distance from nearest water bodies (DWATER) at 0.5 × 0.5 km2 spatial reso-
lution. LC was recoded to the following categories: forests, grasslands, and croplands. Rainfall data were obtained 
from the U.S. Geological Survey-Earth Resources Observation Systems (USGSS) Data Portal, while altitude data 
were extracted from the Shuttle Radar Topography Mission (SRTM) at 0.5 × 0.5 km2 spatial resolution. Locations 
were classified to rural or urban residence according to the Global Rural and Urban Mapping Project.
Statistical analysis. We fitted separate Bayesian geostatistical Weibull survival models, for each one of the 
morbidity indicators considered in our study, i.e. malaria parasitaemia, moderate/severe anemia, severe anemia, 
moderate comorbidity and severe comorbidity, in order to assess their effect on all-cause under-five mortality. 
The outcome of the survival model was the age of death or current age of a child (in months), together with 
the corresponding censoring status, i.e. alive children were considered as censored observations. The indicators 
measured cluster-level prevalence and thus each child was associated with the prevalence at the corresponding 
cluster. Therefore, the prevalence of malaria parasitaemia, anemia, and malaria-anemia comorbidity at a given 
location was treated as an exposure that children receive at that location. For each model, the association between 
the mortality outcome and the corresponding indicator was adjusted for confounders, which were selected based 
on rigorous variable selection procedures, carried out separately for each country. In particular, we fitted separate 
Weibull survival geostatistical models with the candidate covariates and included only the statistically important 
ones (i.e. Bayesian credible interval did not include zero). We used throughout the paper terminology consistent 
with the Bayesian inference and call statistically important effects regression coefficients that are known as sta-
tistically significant in frequentist inference. The variance inflation factor was used to exclude the highly corre-
lated predictors30. The final models included different sets of covariates for each country in order to estimate the 
malaria parasitaemia, anemia, and comorbidity effect from the most parsimonious model. We included spatially 
random effects at cluster level modelled by a Gaussian process with Matérn covariance matrix31.
An additional analysis was carried out to assess the sensitivity of the results to the selected confounders. 
Specifically, we re-fitted the parasitaemia and comorbidity prevalence models using a common set of confounders 
across all countries based on the biggest set derived by combining all country-specific confounders. Furthermore, 
we re-fitted the models with the comorbidity prevalence adjusting for parasitaemia prevalence only (prevalence 
of children with positive parasite test which are not moderate or severe anemic) and moderate-to-severe anemia 
prevalence only (prevalence of moderate or severe anemic children which are not positive for a malaria parasite 
test).
We identified the geographical distribution in the effects of moderate comorbidity on all-cause under-five 
mortality, by fitting a spatially varying coefficient model for each country, assuming a spatially continuous 
Gaussian process on the comorbidity effect. Estimates were summarised by the posterior median, 2·5 and 97·5 
quantiles. The models were adjusted for malaria or anemia interventions, climatic, maternal, individual child, and 
household characteristics.
We used geostatistical models to estimate disease risk surfaces and created national maps based on pixel-based 
estimates. Environmental predictors and spatial random effects were modelled on the logit scale. Prediction was 
carried out into a grid formed by 2 × 2 km2 resolution pixels.
The analysis was conducted in R software (version 3.3.2). We used the integrated nested Laplace approx-
imations (INLA) approach32 to perform fast approximate Bayesian inference. Model details are provided in 
Supplementary Appendix.
ethical approval and consent to participate. In this study we analysed secondary data made available 
by the Demographic Health Survey (DHS) MEASURE. According to survey protocols and related documents of 
the surveys, ethical approval was obtained from the Institutional Review Board of International Consulting Firm 
(ICF) of Calverton, Maryland, USA, and also from the national ethical committees in the countries that the sur-
veys were contacted. Details of ethical clearance are published in the DHS reports available at https://dhsprogram.
com/publications/index.cfm.
Data Availability
The study data are available upon request from the Demographic and Health Surveys program (https://dhspro-
gram.com/).
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